Guiding ICU Physicians' Communication and Behavior Towards Bereaved Relatives (COSMIC)

February 10, 2021 updated by: Assistance Publique - Hôpitaux de Paris

Guiding ICU Physicians' Communication and Behavior Towards Bereaved Relatives: a Randomized Controlled Trial (COSMIC - EOL)

As ICU mortality is high, end-of-life is a subject of major concern for intensivists. With a mortality rate of 20%, end-of-life care has become a daily responsibility. Among those deaths, 60 to 80% follow a decision to withhold or withdraw treatment, situations where physicians, nurses and relatives must work together towards the most consensual decision. In this context, patients' relatives feel vulnerable and, in the months that follow the death, they are most likely to present symptoms that negatively affect their quality of life (anxiety, depression, PTSD, prolonged grief). Many studies have shown that communication with caregivers is one of the most highly valued aspects of care that impacts on family members' experience during the patient's stay and after the patient's death. Improving communication during the end-of-life process in the ICU context is a necessity that has been put forward in palliative care and family-centered care guidelines.

This study aims to improve both communication skills and behaviour by giving precise recommendations to physicians (3 step strategy) in their direct contact with patients' relatives. A 3-step physician-driven support strategy is used, that consists in 3 meetings with the relative - one before, one during and one after the patient's death. The underlying hypothesis is that this strategy will improve communication in the end-of-life setting and thus should reduce post-ICU burden for family members, specifically the development of prolonged grief 6 months after the death.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

900

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Clichy, France, 92
        • Anesthésie Réanimation Beaujon
      • Evry, France
        • Réanimation polyvalente Sud Francilien
      • Paris, France, 75006
        • Réanimation médicale Hôpital Cochin
      • Paris, France, 75010
        • Réanimation médicale
      • Paris, France, 75013
        • Réanimation médicale Pitié Salpetriere
      • Paris, France, 75015
        • Réanimation chirurgicale HEGP
      • Paris, France, 75015
        • Réanimation médicale HEGP
      • Paris, France, 75019
        • Réanimation médico chirurgicale Tenon
      • Pontoise, France, 95
        • Réanimation polyvalente René Dubos
    • Val-de-marne
      • Le Kremlin-Bicêtre, Val-de-marne, France, 94276
        • Réanimation médicale Bicetre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Relatives of patients who died in the intensive care unit after a decision to withhold or withdraw treatment (adult ICUs only, ICU length of stay > 2 days).
  • Consent to participate in the study
  • Relative who was seen at least once by the physician before the patient's death

Exclusion Criteria:

  • Relative that does not understand, read or speak French
  • Relative who refuses to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: standard of care
Experimental: Intervention

All caregivers will receive a leaflet about the importance of end of life (EOL) communication: key elements and recommendations regarding verbal and non-verbal communication.

A "local champion" ("opinion leader") will be designated by each team in order to help implement the strategy. These physicians will help colleagues to connect external knowledge and requirements of the study to the local context.

Development of a 3-step physician-driven support strategy starting after a decision to withhold or withdraw life-sustaining therapies is implemented:

  1. Preparation for the death : Prepare the relative for the patient's imminent death
  2. During the dying and death process: The physician enters the patient's room at least once to check on the relatives
  3. After the patient's death: the physician and the nurse meet the relative

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
PG-13 : Prolonged Grief Disorder-13 that measures symptoms of prolonged grief
Time Frame: 6 months post patient's death
6 months post patient's death

Secondary Outcome Measures

Outcome Measure
Time Frame
CAESAR scale that measured quality of dying and death
Time Frame: 1 month post patient's death
1 month post patient's death
Quality of dying and death (QODD-1)
Time Frame: 1 month post patient's ddeath
1 month post patient's ddeath
Miss-21 - Rapport subscale that describes communication with physician
Time Frame: 1 month post patient's death
1 month post patient's death
Hospital Anxiety and Depression Scale (HADS)
Time Frame: 1, 3 and 6 months post patient's death
1, 3 and 6 months post patient's death
Impact of Event Scale-Revised (IES-R) that measures post-traumatic stress symptoms
Time Frame: 3 and 6 months post patient's death
3 and 6 months post patient's death

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Questionnaire - lifestyle disruption
Time Frame: 6 months post patient's death
Questionnaire developed by the Famiréa Group for relatives about lifestyle disruption
6 months post patient's death
Checklist
Time Frame: 24 hours post patient's death
Checklist for adherence of investigators to the intervention (intervention groups)
24 hours post patient's death

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2017

Primary Completion (Actual)

April 1, 2020

Study Completion (Actual)

January 1, 2021

Study Registration Dates

First Submitted

November 3, 2016

First Submitted That Met QC Criteria

November 3, 2016

First Posted (Estimate)

November 4, 2016

Study Record Updates

Last Update Posted (Actual)

February 12, 2021

Last Update Submitted That Met QC Criteria

February 10, 2021

Last Verified

February 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • AOM15014

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patients Died in Intensive Care Unit (ICU)

Clinical Trials on Improving communication during the end-of-life process

Subscribe